Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Alnylam Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Alnylam Pharmaceuticals (United States)

Cambridgecompany

1,154

Works

628,456

Citations

414

h-index

Top Research Topics

RNA Interference and Gene Delivery Amyloidosis: Diagnosis, Treatment, Outcomes Advanced biosensing and bioanalysis techniques

Top Researchers

Róbert Langer Brigham and Women's Hospital

1,955 works293,848 citationsh-index: 262

Recent Research

Development and validation of the modified-comprehensive Kumamoto Score: a multi-organ assessment tool for hereditary transthyretin amyloidosis

Shiori Yamakawa,T. Nomura,et al.

20260 citations

Porphyrin Metabolism and Disorders

Parathyroid Disorders and Treatments

MicroRNA in disease regulation

DNA and Nucleic Acid Chemistry

Heme Oxygenase-1 and Carbon Monoxide

RNA and protein synthesis mechanisms

Kidney Stones and Urolithiasis Treatments

Neonatal Health and Biochemistry

RNA modifications and cancer

Peter Libby Brigham and Women's Hospital

1,244 works219,134 citationsh-index: 227

David P. Bartel Howard Hughes Medical Institute

314 works196,589 citationsh-index: 121

Ralph Weissleder Massachusetts General Hospital

1,596 works171,040 citationsh-index: 200

Aletta E. Schutte Alnylam Pharmaceuticals (United States)

783 works159,949 citationsh-index: 84

Josep Tabernero Hebron University

2,703 works126,607 citationsh-index: 146

Effect of vutrisiran on components of health status in transthyretin amyloidosis with cardiomyopathy: the HELIOS-B study

Yasuhiro Hamatani,Brian L Claggett,et al.

20260 citations

26-A-15266-ACC POOLED SAFETY ANALYSIS OF ZILEBESIRAN, AN INVESTIGATIONAL LONG-ACTING RNA INTERFERENCE THERAPEUTIC, FROM PHASE 2 STUDIES IN PATIENTS WITH HYPERTENSION

Akshay S. Desai,MANISH SAXENA,et al.

20260 citations

26-A-8295-ACC POLYPHARMACY AND DRUG-DRUG INTERACTIONS AMONG PATIENTS WITH ATTR-CM RECEIVING STABILIZER TREATMENT

Robert J. DiDomenico,A. Patel,et al.

20260 citations

26-A-13919-ACC VUTRISIRAN REDUCES THE RISK OF DEVELOPING ADVANCED DISEASE AND DEMONSTRATES BENEFIT IN PATIENTS WHO DEVELOP ADVANCED DISEASE IN ATTR-CM: ANALYSIS FROM THE HELIOS-B STUDY

Ronald Witteles,Julian D. Gillmore,et al.

20260 citations

26-A-8296-ACC ADHERENCE AND PERSISTENCE WITH VUTRISIRAN, AN RNAI THERAPEUTIC FOR THE TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS

Michael L. Heffernan,Ankur Patel,et al.

20260 citations